2026 Global: Contrast-Enhanced Ultrasound Market -Competitive Review (2032) report
Description
The 2026 Global: Contrast-Enhanced Ultrasound Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Key players in the global contrast-enhanced ultrasound (CEUS) market include Bracco Imaging SpA of Milan, Italy; Lantheus Medical Imaging, Inc., based in North Billerica, Massachusetts, United States; Daiichi Sankyo Company, Limited, headquartered in Tokyo, Japan; and GE HealthCare, headquartered in Boston, United States. Bracco Imaging dominates many European markets with SonoVue, a sulfur hexafluoride microbubble contrast agent approved for vascular and organ-enhancement imaging, and maintains a global footprint through regulatory approvals, manufacturing sites, and a comprehensive education program for sonographers and radiologists. Lantheus Medical Imaging markets Definity, a perflutren-based agent, and operates a widespread U.S. commercial operation that supports hospital adoption through training and imaging guidelines. Daiichi Sankyo contributes Sonazoid, which is used in hepatic CEUS and other inflammatory processes, supported by a robust presence in Japan and expanding markets in Asia and Latin America. GE HealthCare contributes to CEUS by integrating contrast-enhanced imaging into its ultrasound platforms and offering supportive services, with a global sales network that extends into Europe, the Americas, and Asia.
Guerbet SA of Villeurbanne, France, Mindray Medical International Co., Ltd., of Shenzhen, China, Esaote SpA of Genoa, Italy, and Canon Medical Systems Corporation of Ota City, Tokyo, Japan constitute a second cluster of market participants focused on imaging platforms and CEUS compatibility. Guerbet has historically marketed contrast-enhancing solutions and collaborates with clinical societies to standardize CEUS protocols, while maintaining regulatory and distribution channels across Europe and Asia. Mindray, a leading provider of diagnostic ultrasound systems, integrates CEUS into mid- to high-end platforms, enabling physicians to deploy microbubble contrast agents from multiple suppliers based on local approvals. Esaote emphasizes compact, high-value ultrasound systems for abdominal and musculoskeletal imaging, expanding CEUS options through partnerships and software enhancements. Canon Medical Systems delivers CEUS-capable ultrasound machines and integrates spectral Doppler, tissue harmonic imaging, and advanced workflow features to support liver lesion characterization, renal perfusion, and cardiovascular assessment.
Siemens Healthineers AG of Erlangen, Germany, and Samsung Medison Co., Ltd. of Seoul, South Korea complete the group of major CEUS stakeholders with device-centric leadership. Siemens Healthineers provides CEUS-optimized systems across professional practice settings and collaborates with contrast-agent manufacturers to tailor imaging protocols, maintain regulatory compliance, and support training. Samsung Medison offers ultrasound platforms with CEUS functionality and mobile and point-of-care capabilities, leveraging its consumer electronics heritage and strong regional presence in Asia. Collectively, these ten organizations shape CEUS adoption by aligning hardware performance with regulatory norms, operator training, and market access, while fostering cross-border collaborations for guideline harmonization and evidence generation. These collaborations are reinforced by ongoing clinical research, post-market surveillance, and standardized reporting frameworks to quantify CEUS diagnostic accuracy, operator skill requirements, and patient outcomes across liver, renal, cardiac, and oncologic imaging domains in diverse clinical settings worldwide for adaptability.
Key players in the global contrast-enhanced ultrasound (CEUS) market include Bracco Imaging SpA of Milan, Italy; Lantheus Medical Imaging, Inc., based in North Billerica, Massachusetts, United States; Daiichi Sankyo Company, Limited, headquartered in Tokyo, Japan; and GE HealthCare, headquartered in Boston, United States. Bracco Imaging dominates many European markets with SonoVue, a sulfur hexafluoride microbubble contrast agent approved for vascular and organ-enhancement imaging, and maintains a global footprint through regulatory approvals, manufacturing sites, and a comprehensive education program for sonographers and radiologists. Lantheus Medical Imaging markets Definity, a perflutren-based agent, and operates a widespread U.S. commercial operation that supports hospital adoption through training and imaging guidelines. Daiichi Sankyo contributes Sonazoid, which is used in hepatic CEUS and other inflammatory processes, supported by a robust presence in Japan and expanding markets in Asia and Latin America. GE HealthCare contributes to CEUS by integrating contrast-enhanced imaging into its ultrasound platforms and offering supportive services, with a global sales network that extends into Europe, the Americas, and Asia.
Guerbet SA of Villeurbanne, France, Mindray Medical International Co., Ltd., of Shenzhen, China, Esaote SpA of Genoa, Italy, and Canon Medical Systems Corporation of Ota City, Tokyo, Japan constitute a second cluster of market participants focused on imaging platforms and CEUS compatibility. Guerbet has historically marketed contrast-enhancing solutions and collaborates with clinical societies to standardize CEUS protocols, while maintaining regulatory and distribution channels across Europe and Asia. Mindray, a leading provider of diagnostic ultrasound systems, integrates CEUS into mid- to high-end platforms, enabling physicians to deploy microbubble contrast agents from multiple suppliers based on local approvals. Esaote emphasizes compact, high-value ultrasound systems for abdominal and musculoskeletal imaging, expanding CEUS options through partnerships and software enhancements. Canon Medical Systems delivers CEUS-capable ultrasound machines and integrates spectral Doppler, tissue harmonic imaging, and advanced workflow features to support liver lesion characterization, renal perfusion, and cardiovascular assessment.
Siemens Healthineers AG of Erlangen, Germany, and Samsung Medison Co., Ltd. of Seoul, South Korea complete the group of major CEUS stakeholders with device-centric leadership. Siemens Healthineers provides CEUS-optimized systems across professional practice settings and collaborates with contrast-agent manufacturers to tailor imaging protocols, maintain regulatory compliance, and support training. Samsung Medison offers ultrasound platforms with CEUS functionality and mobile and point-of-care capabilities, leveraging its consumer electronics heritage and strong regional presence in Asia. Collectively, these ten organizations shape CEUS adoption by aligning hardware performance with regulatory norms, operator training, and market access, while fostering cross-border collaborations for guideline harmonization and evidence generation. These collaborations are reinforced by ongoing clinical research, post-market surveillance, and standardized reporting frameworks to quantify CEUS diagnostic accuracy, operator skill requirements, and patient outcomes across liver, renal, cardiac, and oncologic imaging domains in diverse clinical settings worldwide for adaptability.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
